Lennard, L., Cartwright, C., Wade, R., Richards, S., Mitchell, C., Kinsey, S., . . . Vora, A. (2010). The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers.
Lua i Stíl Chicago (17ú heag.)Lennard, L., C. Cartwright, R. Wade, S. Richards, C. Mitchell, S. Kinsey, T. Eden, J. Lilleyman, agus A. Vora. The Thiopurine Methyltransferase TPMT *1/*3A Genotype Is Associated with a Better Treatment Outcome in the UK ALL97 Trial for Childhood Acute Lymphoblastic Leukaemia; TPMT Heterozygosity Is Not Associated with Secondary Cancers. 2010.
Lua MLA (9ú heag.)Lennard, L., et al. The Thiopurine Methyltransferase TPMT *1/*3A Genotype Is Associated with a Better Treatment Outcome in the UK ALL97 Trial for Childhood Acute Lymphoblastic Leukaemia; TPMT Heterozygosity Is Not Associated with Secondary Cancers. 2010.